Ocrevus (ocrelizumab) and Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq) are prescription medicines for multiple sclerosis (MS). Both contain the medicine ...
Multiple sclerosis (MS) is a chronic, often disabling condition that affects the central nervous system, disrupting communication between the brain and body. It’s largely thought to occur when the ...
Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for treating nerve damage rather than only suppressing inflammation.
More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results